SCHEMBL4117529

SCHEMBL4117529

COc1cc2c(cc1OC)CN(C(=O)C#Cc1cccc(Cl)c1)CC2

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4B Q07343 2/20 0.55
ABCB1 P08183 1/20 0.52
GAA P10253 1/20 0.52
POLB P06746 2/20 0.52
MAPT P10636 3/20 0.51
NPSR1 Q6W5P4 2/20 0.51
HPGD P15428 1/20 0.51
HTT P42858 1/20 0.51
KMT2A Q03164 3/20 0.50
HSD17B10 Q99714 3/20 0.50
KDM4E B2RXH2 2/20 0.50
ALOX15 P16050 1/20 0.50
NPC1 O15118 1/20 0.50
MAPK1 P28482 1/20 0.50
THRB P10828 1/20 0.50
MEN1 O00255 2/20 0.49
ALDH1A1 P00352 2/20 0.49
MDM2 Q00987 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.48
PDE4D Q08499 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4113168 0.94 DRD3 (0.51) PDE4BABCB1GAAPOLBMAPT
SCHEMBL4112911 0.94 DRD3 (0.51) PDE4BABCB1GAAPOLBMAPT
SCHEMBL4123261 0.88 GRM5 (0.47) PDE4BKMT2ANPC1MEN1TSHR
SCHEMBL4111406 0.88 ESR1 (0.52) PDE4BKMT2ANPC1MEN1TSHR
SCHEMBL4111107 0.87 ERCC1 (0.49) PDE4BABCB1KMT2ANPC1MEN1
SCHEMBL4113280 0.87 GRM5 (0.44) PDE4BABCB1ALOX15NPC1TSHR
SCHEMBL4117672 0.87 ABHD6 (0.50) PDE4BABCB1ALOX15NPC1TSHR
SCHEMBL4111987 0.85 NPC1 (0.56) PDE4BGAAPOLBMAPTNPSR1
SCHEMBL4115927 0.84 GRM5 (0.46) PDE4BNPSR1KMT2ANPC1MAPK1
SCHEMBL4124858 0.84 GRM5 (0.46) PDE4BNPSR1KMT2ANPC1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090075978-A1 SUBSTITUTED PROPIOLIC ACID AMIDES AND THEIR USE FOR PRODUCING DRUGS GRUNENTHAL GMBH (DE) 2009-03-19 US claimed
US-20090075978-A1 SUBSTITUTED PROPIOLIC ACID AMIDES AND THEIR USE FOR PRODUCING DRUGS GRUNENTHAL GMBH (DE) 2009-03-19 US disclosed
US-20090075978-A1 SUBSTITUTED PROPIOLIC ACID AMIDES AND THEIR USE FOR PRODUCING DRUGS GRUNENTHAL GMBH (DE) 2009-03-19 US disclosed
EP-1968938-A1 SUBSTITUTED PROPIOLIC ACID AMIDES AND THEIR USE FOR PRODUCING DRUGS Grünenthal GmbH (DE) 2008-09-17 EP disclosed
WO-2007079957-A1 SUBSTITUTED PROPIOLIC ACID AMIDES AND THEIR USE FOR PRODUCING DRUGS Grünenthal GmbH (DE) 2007-07-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090075978-A1 SUBSTITUTED PROPIOLIC ACID AMIDES AND THEIR USE FOR PRODUCING DRUGS PCCA, PPARA, PTGES PDE4B 1315/4885ABCB1 350/4885GAA 1341/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.